BioSpace News Archive

Today, Kenneth E. Thorpe, chairman of the Partnership to Fight Chronic Disease, issued the following statement regarding the coronavirus emergency funding package

Leading Facilities Select Cloud Platform to Solve Complex Enterprise Workflows

The Allen Institute and Sage Bionetworks announced winners of the Allen Institute Cell Lineage Reconstruction DREAM Challenge

City of Hope scientists have developed and tested the first chimeric antigen receptor (CAR) T cell therapy using chlorotoxin (CLTX), a component of scorpion venom, to direct T cells to target brain tumor cells, according to a preclinical study published today in Science Translational Medicine

Physicians’ Education Resource® (PER®), a leading resource for continuing medical education, will conduct a satellite symposium titled “Severe Asthma Through the Ages: Personalized Management for Difficult-to-Treat Children, Adolescents, and Adults” adjunct to the 2020 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting.

Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for bone fusion procedures, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an expanded indication for its AgilonTM moldable bone grafting product.

Flexion Therapeutics, Inc. announced that it will report its fourth-quarter and full-year 2019 financial results after the close of the U.S. financial markets on Thursday, March 12, 2020.